Publications by authors named "B Eustace"

Article Synopsis
  • Transfusion-dependent β-thalassemia (TDT) and sickle cell disease (SCD) are serious genetic disorders that require ongoing medical treatment and can be life-threatening.
  • Researchers utilized CRISPR-Cas9 technology to modify CD34+ stem cells from healthy donors, targeting a specific enhancer to increase fetal hemoglobin production by altering BCL11A, a gene that suppresses it.
  • Two patients, one with TDT and the other with SCD, received these edited cells after a preparative procedure and showed significant improvements after a year, including high fetal hemoglobin levels, independence from blood transfusions, and reduced complications from SCD.
View Article and Find Full Text PDF

This work demonstrates the application of a 3D culture system-Cells-in-Gels-in-Paper (CiGiP)-in evaluating the metabolic response of lung cancer cells to ionizing radiation. The 3D tissue-like construct-prepared by stacking multiple sheets of paper containing cell-embedded hydrogels-generates a gradient of oxygen and nutrients that decreases monotonically in the stack. Separating the layers of the stack after exposure enabled analysis of the cellular response to radiation as a function of oxygen and nutrient availability; this availability is dictated by the distance between the cells and the source of oxygenated medium.

View Article and Find Full Text PDF

A multilayered paper-based platform is used to investigate the interactions between human lung tumor cells and fibroblasts that are isolated from primary patient tumor samples.

View Article and Find Full Text PDF

This work describes a 3D, paper-based assay that can isolate sub-populations of cells based on their invasiveness (i.e., distance migrated in a hydrogel) in a gradient of concentration of oxygen (O2).

View Article and Find Full Text PDF

Platinum-based DNA-damaging chemotherapy is standard-of-care for most patients with lung cancer but outcomes remain poor. This has been attributed, in part, to the highly effective repair network known as the DNA-damage response (DDR). ATR kinase is a critical regulator of this pathway, and its inhibition has been shown to sensitize some cancer, but not normal, cells in vitro to DNA damaging agents.

View Article and Find Full Text PDF